Study of an All Polyethylene Tibial Component
A Prospective Study of an All Polyethylene Tibial Component Used in Total Knee Arthroplasty Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
This will be a prospective single cohort investigation of the Columbus all polyethylene tibia (Aesculap AG, Tuttlingen, Germany) used in total knee arthroplasty (TKA) surgery. The aim of the project is to determine post-operative outcome of the all polyethylene tibia up to two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2015
CompletedFirst Posted
Study publicly available on registry
September 4, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedMay 24, 2019
May 1, 2019
3.5 years
August 11, 2015
May 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone mineral density
Measure of peri-prosthetic bone mineral density
18 to 24 months post-operatively
Secondary Outcomes (13)
Intra-operative RoM
Intra-operative
Intra-operative alignment
Intra-operative
RoM
1 year
Oxford Knee Score
1 year
EQ-5D
1 year
- +8 more secondary outcomes
Study Arms (1)
All-poly
EXPERIMENTALKnee arthroplasty with all-polyethylene tibia
Interventions
Implantation of an all polyethylene tibial component.
Eligibility Criteria
You may qualify if:
- Unilateral TKA
- Aged 70 year or older
- BMI \< 37.5
- Suitable to receive the study implant
You may not qualify if:
- Revision of existing knee replacement
- Previous lower limb replacement
- Proximal tibial bone defects
- Diagnosed osteopenia or osteoporosis
- Unable to give informed consent
- Unwilling to take part
- Unable to return to the Golden Jubilee National Hospital for followup appointments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Golden Jubilee National Hospitallead
- Aesculap AGcollaborator
Study Sites (1)
Golden Jubilee National Hospital
Clydebank, West Dunbartonshire, G81 4DY, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Frederic Picard, MD
Golden Jubilee National Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2015
First Posted
September 4, 2015
Study Start
October 1, 2015
Primary Completion
April 12, 2019
Study Completion
October 1, 2019
Last Updated
May 24, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share